Economic impact of moderate weight loss in patients with Type2 diabetes: The Fremantle Diabetes Study

Diabetic Medicine

Volumn 28, Issue 9, 2011, Pages 1131-1135

  Davis, W A ^a   Bruce, D G ^a   Davis, T M E ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Cost analysis; Glycaemic control; Type 2 diabetes; Weight loss

Indexed keywords

ANTILIPEMIC AGENT; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGE; AGED; ARTICLE; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; COST CONTROL; DIABETIC PATIENT; DISEASE DURATION; DRUG COST; FEMALE; FOLLOW UP; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; SYSTOLIC BLOOD PRESSURE; WEIGHT REDUCTION;

BLOOD GLUCOSE; BODY WEIGHT; COST-BENEFIT ANALYSIS; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; OBESITY; WEIGHT LOSS;

EID: 80051612369     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2011.03314.x     Document Type: Article

References (24)

1. UKPDS Group. Response of fasting plasma glucose to diet therapy in newly presenting type II diabetic patients. UK Prospective Diabetes Study 7. Metabolism 1990; 39: 905-912.
2. Wing RR, Koeske R, Epstein LH, Nowalk MP, Gooding W, Becker D. Long-term effects of modest weight loss in typeII diabetic patients. Arch Intern Med 1987; 147: 1749-1753.
3. The Look AHEAD Research Group. Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes. One-year results of the Look AHEAD trial. Diabetes Care 2007; 30: 1374-1383.
4. Collins RW, Anderson JW. Medication cost savings associated with weight loss for obese non-insulin-dependent diabetic men and women. Prev Med 1995; 24: 369-374.
5. Anderson DA, Wadden TA. Treating the obese patient. Suggestions for primary care practice. Arch Fam Med 1999; 8: 156-167.
6. Pories WJ, MacDonald KG Jr, Morgan EJ, Sinha MK, Dohm GL, Swanson MS et al. Surgical treatment of obesity and its effect on diabetes: 10-year follow-up. Am J Clin Nutr 1992; 55: 582S-585S.
7. Bruce DG, Davis WA, Davis TME. Glycaemic control in elderly subjects with type2 diabetes mellitus in the Fremantle Diabetes Study. J Am Geriatr Soc 2000; 48: 1449-1453.
8. Gudex C, Kind P. The QALY Toolkit. York: Centre for Health Economics The University of York, 1988.
9. Diabetes Control and Complications Trial Study Group. Reliability and validity of a diabetes quality-of-life measure for the Diabetes Control and Complications Trial (DCCT). Diabetes Care 1988; 11: 725-732.
10. Davis TM, Clifford RM, Davis WA. Effect of insulin therapy on quality of life in Type2 diabetes mellitus: The Fremantle Diabetes Study. Diabetes Res Clin Pract 2001; 52: 63-71.
11. Davis T, Zimmet P, Davis W, Bruce D, Fida S, Mackay I. Autoantibodies to glutamic acid decarboxylase in diabetic patients from a multi-ethnic Australian community: the Fremantle Diabetes Study. Diabet Med 2000; 17: 667-674.
12. Han TS, Vanleer EM, Seidell JC, Lean MEJ. Waist circumference action levels in the identification of cardiovascular risk-factors - prevalence study in a random sample. Br Med J 1995; 311: 1401-1405.
13. Norman PE, Davis WA, Bruce DG, Davis TME. Peripheral arterial disease and risk of cardiac death in type2 diabetes: The Fremantle Diabetes Study. Diabetes Care 2006; 29: 575-580.
14. Commonwealth Department of Health and Aged Care. Schedule of Pharmaceutical Benefits. Canberra: Commonwealth Department of Health and Aged Care, 2000.
15. Holman CD, Bass AJ, Rouse IL, Hobbs MS. Population-based linkage of health records in Western Australia: development of a health services research linked database. Aust N Z J Public Health 1999; 23: 453-459.
16. Efron B, Tibshirani RJ. An Introduction to the Bootstrap. Boca Raton, FL: Chapman & Hall/CRC Press, 1994.
17. Goldstein DJ. Beneficial health effects of modest weight loss. Int J Obes Relat Metab Disord 1992; 16: 397-415.
18. Pi-Sunyer FX. Short-term medical benefits and adverse effects of weight loss. Ann Intern Med 1993; 119: 722-726.
19. Barr ELM, Magliano DJ, Zimmet PZ, Polkinghorne KR, Atkins RC, Dunstan DW et al. AusDiab 2005. The Australian Diabetes, Obesity and Lifestyle Study. Melbourne: International Diabetes Institute, 2006.
20. Shoff SM, Klein R, Moss SE, Klein BE, Cruickshanks KJ. Weight change and glycaemic control in a population-based sample of adults with older-onset diabetes. J Gerontol Ser A Biol Sci Med Sci 1998; 53: M27-M32.
21. Reaven GM. Beneficial effect of moderate weight loss in older patients with non-insulin-dependent diabetes mellitus poorly controlled with insulin. J Am Geriatr Soc 1985; 33: 93-95.
22. Barinas-Mitchell E, Kuller LH, Sutton-Tyrell K, Hegazi R, Harper P, Mancino J et al. Effect of weight loss and nutritional intervention on arterial stiffness in type2 diabetes. Diabetes Care 2006; 29: 2218-2222.
23. Avenell A, Broom J, Brown TJ, Poobalan A, Aucott L, Stearns SC et al. Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement. Health Technol Assess 2004; 8: 1-182.
24. Picot J, Jones J, Colquitt JL, Gospodarevskaya E, Loveman E, Baxter L, Clegg AJ. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Health Technol Assess 2009; 13: 1-190.